-
Shell completes sale of Jiffy Lube International and Premium Velocity Auto to Monomoy Capital Partners
HOUSTON, July 1, 2026 /PRNewswire/ — Pennzoil Quaker State Company DBA SOPUS Products, a wholly owned subsidiary of Shell USA, Inc., that comprises Shell’s United States (“U.S.”) lubricants business, has completed the previously announced sale of Jiffy Lube International (JLI) and its subsidiary Premium Velocity Auto (PVA) LLC business to an affiliate of Monomoy Capital…
-
FitsAir and Amadeus sign global distribution agreement to expand international reach
COLOMBO, Sri Lanka, July 1, 2026 /PRNewswire/ — FitsAir, Sri Lanka’s privately owned international airline, and Amadeus, a leading travel technology company, today announced the signing of a global distribution agreement. The agreement will make FitsAir’s full range of content available to travel sellers worldwide through the Amadeus Travel Platform, supporting the airline’s continued international…
-
Tulip Innovation and Sunwoda Enter Patent License Agreement
BUDAPEST, Hungary and SHENZHEN, China, June 11, 2026 /PRNewswire/ — Sunwoda Electronic (Sunwoda), a leading global provider of lithium-ion battery technologies and solutions, and Tulip Innovation (Tulip), the licensing agent for lithium-ion battery patents owned by LG Energy Solution and Panasonic Energy, have entered into a patent license agreement under Tulip’s lithium-ion battery licensing program.…
-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the…
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas June 07, 2026 19:41 ET Â | Source: GNI Group Co., Ltd. TOKYO, June 07, 2026 (GLOBE NEWSWIRE) — GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares…
-
Havih, a Maxwell Biosciences Subsidiary, Announces Partnership with the Government of Andhra Pradesh
This partnership will establish a new research and production facility in Andhra Pradesh, driving India’s transition toward pharmaceutical leadership and creating high-tech jobs Pulivendula, Andhra Pradesh, India Havih Envirosciences, an Indian citizen-owned and operated life sciences company and subsidiary of Maxwell Biosciences, announced a strategic partnership with the Government of Andhra Pradesh to establish advanced…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.